Expression, regulation and function of the ISGylation system in prostate cancer (Q39853440)

15 September 2017

Expression, regulation and function of the ISGylation system in prostate cancer (English)

1 reference

15 September 2017

1 reference

B Seliger

7

0 references

Ludger A Wessjohann

object named as

L Wessjohann

6

0 references

author name string

A Kiessling

1

1 reference

15 September 2017

C Hogrefe

2

1 reference

15 September 2017

S Erb

3

1 reference

15 September 2017

C Bobach

4

1 reference

15 September 2017

S Fuessel

5

1 reference

15 September 2017

language of work or name

English

0 references

publication date

11 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

28

1 reference

15 September 2017

2606-2620

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.115

15 September 2017

0 references

cites work

Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen receptor levels are increased by interferons in human prostate stromal and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Molecular characterization of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Second-generation interferons for cancer: clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

ISG15 as a novel tumor biomarker for drug sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

UBE1L causes lung cancer growth suppression by targeting cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Proteomic identification of proteins conjugated to ISG15 in mouse and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Efp as a primary estrogen-responsive gene in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Interplay of nuclear factor-kappaB and B-myb in the negative regulation of androgen receptor expression by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Cyclin D3 action in androgen receptor regulation and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

A model for p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Regulatory processes affecting androgen receptor expression, stability, and function: potential targets to treat hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Expression of estrogen-responsive finger protein (Efp) is associated with advanced disease in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Estrogen-responsive finger protein as a new potential biomarker for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

17beta-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-beta- and extracellular-signal regulated kinase-dependent pathways in LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Link between the ubiquitin conjugation system and the ISG15 conjugation system: ISG15 conjugation to the UbcH6 ubiquitin E2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Negative regulation of protein phosphatase 2Cbeta by ISG15 conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Negative regulation of ISG15 E3 ligase EFP through its autoISGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.115

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.115

1 reference

15 September 2017

1 reference